Care coach-led palliative surgical and rehabilitation care for people with advanced cancer
Official title: Effectiveness of A Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model in Patients With Advanced Cancer Undergoing Major Surgery: A Randomized Controlled Trial
Run by Singapore General Hospital · NCT07133269 · Data updated 2026-11-12
This program will test whether a care coach-led palliative surgical oncology approach paired with rehabilitation helps adults with stage 3–4 solid cancers who are planning major elective surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 99 Years |
| Sex | All |
| Enrollment | 770 (estimated) |
| Sponsor | Singapore General Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Singapore and 1 other locations) |
| Status | Recruiting |
| Started | August 20, 2025 |
| Main results expected | October 2027 |
| Study ends | April 2028 |
| Registry record updated | February 12, 2026 |
| Trial ID | NCT07133269 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 21 or older with stage 3–4 solid-organ cancers or cancers requiring complex major elective surgery who can read and speak English or Chinese (and their unpaid family caregivers) are the ideal candidates.
✕Probably not a fit
Patients who require specialty palliative care for complex needs, those undergoing emergency or non-elective surgery, younger than 21, or unable to read/speak English or Chinese are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants receive a care coach-led palliative surgical oncology intervention integrated with tailored rehabilitation before and after major elective surgery. The care coach-supported surgical team provides basic palliative care elements such as serious illness conversations, symptom management, and psychosocial support alongside functional restoration. Outcomes include patient function, symptom burden, quality of life, and health care use such as readmissions. Caregivers and clinical staff are engaged for qualitative feedback on implementation and acceptability.
Why it matters
Potential benefit: If successful, this approach could improve function, symptom control, quality of life, and reduce post-surgical readmissions for patients with advanced cancer.
How similar studies have gone: Integrated palliative care in surgical settings is relatively novel but pilot data and other integrated palliative models suggest feasibility and potential benefit.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: (i) Patients: 1. Aged 21 and above, 2. Diagnosis of advanced cancer, i.e. stage 3 or 4 solid organ cancer or diagnosed with cancer that requires complex surgery, 3. Planned for elective major surgery (Table of Surgical Procedures (TOSP) table code 4 or more or surgery involves more than one surgical discipline, 4. Able to speak and read English or Chinese (ii) Caregivers: 1. Age 21 and above, 2. Unpaid family or informal caregiver who takes direct care of the patient's day-to-day and healthcare needs, or ensures provision of care to meet the needs, or who is the decision maker with regard to the patient's needs and healthcare, 3. Able to speak and read English or Chinese. (iii) Healthcare Providers (Qualitative interview only): 1. Age 21 and above, 2. Currently working as a Healthcare professional at SGH or NCCS and involved in this study. Exclusion Criteria: (i) Patients: 1. Patient refusal, 2. Have complex PC needs requiring specialty palliative care (SPC) intervention before surgery, 3. Active mental illness or severe dementia and certified unfit to make medical decision by a specialist physician, 4. Scheduled for Emergency surgery. (ii) Caregivers: 1\. Unwilling to participate in the study. (iii) Healthcare Providers (Qualitative interview only): 1\. Unwilling to participate in the Qualitative interview.
Where it's running
-
National Cancer Centre Singapore
Singapore, Singapore Recruiting -
Singapore General Hospital
Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Jolene Wong, MBBS, MMed (Surgery), MPH — Singapore General Hospital
- Study coordinator: Perlie Ng
- Email: perlie.ng.x.y@nccs.com.sg
- Phone: +65 6306 1913
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Concise coaching to guide decisions for advanced cancer patients considering palliative procedures
A coaching program delivered by lay providers will test whether it helps adults with advanced cancer make better, patient-aligned decisions about palliative surgeries or similar interventions.
-
Primary Palliative Care: A Feasibility Project for Family Health Units
This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.
-
Virtual Group Resilient Living for Advanced Cancer
A group-based online program tests whether seven weekly sessions can reduce anxiety and fatigue and improve quality of life for adults with advanced cancer.
-
IV contrast-enhanced CBCT with HyperSight for image guidance in advanced cancer radiotherapy
This study tests whether giving IV contrast during cone-beam CT helps doctors see the tumor better during radiotherapy in people with advanced cancer.
-
Single-session celiac plexus SBRT using a simulation-free adaptive workflow for cancer-related pain
A pilot test to see if a one-day, simulation-free adaptive radiotherapy process can safely deliver celiac plexus SBRT to adults with advanced pancreatic or other cancers.
-
UI-102 in advanced cancers (phase 1/2) first-in-human
A first-in-human study tests UI-102, given to adults with advanced solid tumors to see if it is safe and shows signs of benefit.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.